Related Experiment Videos
Calcium channels and channelopathies of the central nervous system
1Dept of Biomedical Sciences, Univ of Padova, Italy. dani@civ.bio.unipd.it
Abstract:
Several inherited human neurological disorders can be caused by mutations in genes encoding Ca2+ channel subunits. This review deals with known human and mouse calcium channelopathies of the central nervous system (CNS). The human diseases comprise: 1) a recessive retinal disorder, X-linked congenital stationary night blindness, associated with mutations in the CACNA1F gene, encoding alpha(1)1.4 subunits of L-type channels; and 2) a group of rare allelic autosomal dominant human neurological disorders including familial hemiplegic migraine, episodic ataxia type 2, and spinocerebellar ataxia type 6, all associated with mutations in the CACNA1A gene, encoding alpha(1)2.1 subunits of P/Q-type calcium channels. Mutations at the mouse orthologue of the CACNA1A gene cause a group of recessive neurological disorders, including the tottering, leaner, and rocker phenotypes with ataxia and absence epilepsy, and the rolling Nagoya phenotype with ataxia without seizures. Two other spontaneous mouse mutants with ataxia and absence epilepsy, lethargic and stargazer, have mutations in genes encoding a calcium channel auxiliary beta subunit and a putative calcium channel auxiliary gamma subunit. For each channelopathy, the review describes disease phenotype, channel genotype, and known functional consequences of the pathological mutations; in some cases, it also describes working hypothesis and/or speculations addressing the challenging question of how the alterations in channel function lead to selective cellular dysfunction and disease.
Insights
Mutations in calcium channel genes cause inherited neurological disorders in humans and mice. This review details these calcium channelopathies, linking gene mutations to specific disease phenotypes and functional consequences.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Inherited neurological disorders are often linked to mutations in genes responsible for calcium (Ca2+) channel subunits.
- Calcium channelopathies represent a significant group of these genetic neurological conditions.
Purpose of the Study:
- To review known human and mouse calcium channelopathies affecting the central nervous system (CNS).
- To correlate specific gene mutations with observed disease phenotypes and functional consequences.
Main Methods:
- Literature review of human and mouse models of calcium channelopathies.
- Analysis of genotype-phenotype correlations for various neurological disorders.
- Examination of functional consequences of pathological calcium channel mutations.
Main Results:
- Human diseases reviewed include X-linked congenital stationary night blindness (CACNA1F gene) and autosomal dominant disorders like familial hemiplegic migraine, episodic ataxia type 2, and spinocerebellar ataxia type 6 (CACNA1A gene).
- Mouse models with mutations in CACNA1A exhibit phenotypes such as ataxia and absence epilepsy (tottering, leaner, rocker) or ataxia without seizures (rolling Nagoya).
- Other mouse mutants (lethargic, stargazer) show mutations in auxiliary calcium channel subunits (beta and gamma).
Conclusions:
- Mutations in calcium channel genes lead to diverse neurological disorders in both humans and mice.
- Understanding these calcium channelopathies provides insights into selective cellular dysfunction and disease mechanisms.